Oncotarget Controlling Glycolytic Flux: Therapy Challenges and Solutions In a new editorial paper, researchers from the University of Oxford explore challenges and potential... read more February 16, 2023
Oncotarget The Importance of CD56 in the Fight Against Multiple Myeloma In a new Oncotarget editorial, researchers discussed their study on CD56 in multiple myeloma.The... read more February 2, 2023
Oncotarget Researchers Identify New Drug Candidates to Treat DLST+ Tumors The increased expression of DLST has recently been associated with increased tumor aggression and a... read more January 19, 2023
Oncotarget Novel Antibody Drug Conjugate Improves Murine Acute Myeloid Leukemia Researchers from Astellas Pharma Inc. investigated the efficacy of a novel antibody drug conjugate combined... read more January 4, 2023
Oncotarget A New Method of Targeting Exosomes in Precision Medicine Oncotarget published a new editorial perspective by Dr. Mujib Ullah, entitled, "The future of bioorthogonal-chemistry... read more December 20, 2022
Oncotarget Plasma Growth Hormone in HCC: A Biomarker of Response to Atezo/Bev? In a new study, researchers investigated the plasma growth hormone as a potential biomarker of... read more December 8, 2022
Oncotarget New Target Fights Ferroptosis- and Radio-Resistance in Lung Cancers Researchers published a research perspective about a recent study that uncovered FSP1 as a novel... read more November 2, 2022
Oncotarget Synergy of HDACi, PARPi and Chemotherapeutics Against Blood Cancer Researchers investigated the efficacy of HDAC inhibitors in combination with PARP inhibitors and chemotherapeutic drugs... read more October 19, 2022
Oncotarget CRISPR Screens Identify Novel Targets for Personalized Cancer Therapy In this trending new study, researchers used CRISPR-based genome-wide screens to identify genetic determinants of... read more October 7, 2022
Oncotarget How High Altitudes Influence HIF-1, Gastric Cancer & Patient Survival In a new study, researchers evaluated the high altitude in Ecuador and how it may... read more September 27, 2022